Seminars in Hematology
Volume 46 , Pages S1-S4 , April 2009

New Directions in the Treatment of Patients With Chronic Myeloid Leukemia: Introduction

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Financial support for medical editorial assistance was provided by Novartis Pharmaceuticals.

 STATEMENT OF CONFLICT OF INTEREST: Dr Baccarani has received honoraria for consultancies and served on the Advisory Board and as a Speaker for Novartis Pharmaceuticals Corp.

PII: S0037-1963(09)00017-1

doi: 10.1053/j.seminhematol.2009.01.006

Seminars in Hematology
Volume 46 , Pages S1-S4 , April 2009

Article Tools

* Image Usage & Resolution